# Effect of MYODM on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1

> **NCT04634682** · NA · COMPLETED · sponsor: **Myogem Health Company, S.L.** · enrollment: 30 (actual)

## Conditions studied

- Myotonic Dystrophy 1

## Interventions

- **DIETARY_SUPPLEMENT:** MYODM

## Key facts

- **NCT ID:** NCT04634682
- **Lead sponsor:** Myogem Health Company, S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-09
- **Primary completion:** 2021-11-15
- **Final completion:** 2021-12-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04634682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04634682, "Effect of MYODM on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04634682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*